Quarterly report [Sections 13 or 15(d)]

SHARE-BASED COMPENSATION (Tables)

v3.25.1
SHARE-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Issued The following table summarizes the restricted stock issuances approved by Main Street’s Board of Directors under the Equity and Incentive Plan, net of shares forfeited, if any, and the remaining shares of restricted stock available for issuance as of March 31, 2025.
Restricted stock authorized under the plan 5,000,000
Less net restricted stock granted (1,054,323)
Restricted stock available for issuance as of March 31, 2025
 3,945,677
As of March 31, 2025, the following table summarizes the restricted stock issued to Main Street’s non-employee directors and the remaining shares of restricted stock available for issuance pursuant to the Main Street Capital Corporation 2022 Non-Employee Director Restricted Stock Plan. These shares are granted upon appointment or election to the board and vest on the day immediately preceding the annual meeting of stockholders following the respective grant date and are expensed over such service period.
Restricted stock authorized under the plan 300,000
Less net restricted stock granted (11,065)
Restricted stock available for issuance as of March 31, 2025
 288,935
Schedule of Summarized Restricted Stock Awards
Summarized RSA activity for the three months ended March 31, 2025 is as follows:
Three Months Ended March 31, 2025
Number Weighted-Average Grant-Date Fair Value
Restricted Stock Awards (RSAs): of Shares ($ per share)
Non-vested, December 31, 2024
 1,039,417  $ 43.62 
Granted (1) 6,127  59.58 
Vested (1)(2)
 —  — 
Forfeited (411) 47.88 
Non-vested, March 31, 2025
 1,045,133  $ 43.71 
Aggregate intrinsic value as of March 31, 2025 (in thousands)
 $ 59,113  (3)
,___________________________
(1)Restricted units generally vest over a three-year or five-year period from the grant date (as noted above).
(2)No RSAs vested during the three months ended March 31, 2025.
(3)Aggregate intrinsic value is the product of total non-vested restricted shares as of March 31, 2025 and $56.56 per share, the closing price of our common stock on March 31, 2025.